Trastuzumab Combined With Pertuzumab for Adjuvant Treatment of Breast Cancer After Neoadjuvant Therapy

NCT04973319 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

450

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Pyrotinib
DRUG: Trastuzumab

Sponsor

Shengjing Hospital